Unit Dose Packaging

At Tjoapack, we process more than 1.6 million bottles each year, performing oral solids’ bottle filling for clients all over the world. We offer the flexibility for both high and low volume and our equipment can handle bottles of various shapes for 10 to 1,000 tablets. Primary and Secondary Bottle Packagi...

Over the past 30 years Tjoapack has developed significant capabilities and expertise in biotechnology packaging. This has been mostly driven by innovation in the space and a move towards self-administration and patient-centricity. At Tjoapack, we have a specially-trained team in place to tackle the challe...

Our team of specialists can tailor our offering to manage the most complex packaging requirements. Our capabilities include: - Vial labelling, re-labelling and over-labelling - Cartoning of single and multi-packs - Cold chain packaging and storage - Kitting https://youtu.be/hzKBghVqFTc

Our postponement packaging solutions, also known as late-stage customisation, allow our clients to supply their products to markets in response to known demand as opposed to forecasted demand. This leads to improvement in supply chain efficiency and reduction of product wastage.

At Tjoapack, we provide expert packaging solutions for Pre-Filled Syringes, including assembly, labelling, blistering and cartoning. Our line is able to pack Pre-filled syringes of 1 to 5 ml, with or without safety device, and has the opportunity to manually add customer specific components. Our expertise...

At Tjoapack, we use our expertise and experience to ensure the highest level of quality across all of our operations. Our in-house qualified persons (QPs) test and check the entire production process before releasing a finished product to the market for sale. Fully approved by the EMA and the FDA, among o...

Tjoapack's packaging and supply chain solutions help our customers to make the world a healthier place. Our expert team work to facilitate your life sciences research, production and the delivery of medicines to patients across the globe.
We offer: - Packaging solutions for; oral solid blisters a...

In this written panel discussion experts in the pharmaceutical packaging industry comment on the current state of sustainability in packaging, and what can be done to improve this in the future.

At Pharmapack Europe 2023, we spoke to some of our exhibitors about the products they were showcasing at this year's event, and asked for their insights into the packaging market for the year ahead. 

Global contract packaging organisation (CPO), Tjoapack, has announced a €10m+ investment into its packaging and supply chain facility in Etten-Leur, Netherlands over the next two years.

Global contract packaging organisation (CPO), Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials.

At Tjoapack we're dedicated to shaping the future of the pharmaceutical supply chain which is why we're delighted to announce that over the next two years we'll be expanding our facility in Etten-Leur from 8,400sq.m. to 11,500 sq.m.

The investment of over €10m will more than double our primary packaging capacity for oral solids, as well as bolster our warehousing and cold chain capabilities to meet demand for our value-added logistics services.

Read more here

Tjoapack Netherlands B.V., a global contract packaging organisation (CPO) for the pharmaceutical industry, today announced a majority investment from Ampersand Capital Partners, a private equity firm that specializes in partnering with entrepreneur-led healthcare companies.  Ampersand’s investment will be used to expand Tjoapack’s capabilities to meet growing industry demand for high quality pharmaceutical packaging services across different dosage forms.

At Tjoapack we’re committed to ensuring we consistently bolster our offering and deliver the efficient and flexible services that our clients expect.

That is why we are excited to announce our most recent investment into our automated injectables packaging capabilities which will begin operations in 2021!

Learn more about our current syringe and vial packaging offerings here

The CPO has immediate plans to expand its automated packaging capabilities, including for injectable products.

Postponement packaging is the practice of keeping products in a semi-finished, market agnostic state, and only finalising them when there is a specific market demand.

Used strategically, it will allow pharmaceutical manufacturers to respond to market-related fluctuation as well as variations in packaging requirements. In addition, postponement will enable pharma companies to lower working capital by reducing finished goods inventories, avoid repackaging work, reduce waste across the supply chain, and shorten their return on investment cycle.

In this whitepaper, Dr Anita Paz, Innovation Consultant and Dexter Tjoa, CEO (formerly Director Corporate Strategy) at Tjoapack, outline the postponement packaging principle and the key points to consider before implementing it as a supply chain strategy. They also discuss how this approach can be applied to different product portfolios and the benefits that adoption could bring to the pharmaceutical industry.

For more information on postponement packaging visit

We're delighted to announce today that Tjoapack has received a majority investment from Ampersand Capital Partners, a private equity firm specialising in the pharmaceutical and healthcare industry. The investment will allow us to continue to expand our capabilities and capacity to meet rising customer demand, as well as help support us in achieving our long-term strategic growth.

In addition to the investment, Dexter Tjoa, our Director Corporate Strategy, has been appointed as the new CEO taking over from our founder, Eric Tjoa. Eric will maintain a seat on the Board alongside our new investors.

Read more about the investment here

Challenge us...